Raymond James Forecasts Strong Price Appreciation for Intuitive Surgical (NASDAQ:ISRG) Stock

Intuitive Surgical (NASDAQ:ISRG) had its price target boosted by Raymond James from $560.00 to $688.00 in a research report released on Friday morning,Benzinga reports. Raymond James currently has an outperform rating on the medical equipment provider’s stock.

A number of other equities analysts have also weighed in on ISRG. Erste Group Bank upgraded Intuitive Surgical from a “hold” rating to a “buy” rating in a research note on Tuesday, November 19th. Wells Fargo & Company increased their target price on Intuitive Surgical from $630.00 to $687.00 and gave the stock an “overweight” rating in a research note on Friday. Citigroup increased their target price on Intuitive Surgical from $640.00 to $711.00 and gave the stock a “buy” rating in a research note on Friday. Mizuho increased their target price on Intuitive Surgical from $440.00 to $500.00 in a research note on Thursday, October 17th. Finally, Piper Sandler restated an “overweight” rating and set a $670.00 price objective (up previously from $538.00) on shares of Intuitive Surgical in a research note on Friday. One investment analyst has rated the stock with a sell rating, three have given a hold rating and fifteen have issued a buy rating to the stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $583.83.

Intuitive Surgical Stock Down 4.0 %

ISRG opened at $584.05 on Friday. Intuitive Surgical has a 12-month low of $364.17 and a 12-month high of $616.00. The stock has a market cap of $208.03 billion, a price-to-earnings ratio of 93.90, a PEG ratio of 5.19 and a beta of 1.39. The business has a 50 day moving average of $547.16 and a 200-day moving average of $504.78.

Insider Activity at Intuitive Surgical

In other Intuitive Surgical news, EVP Robert Desantis sold 188 shares of the stock in a transaction that occurred on Tuesday, October 29th. The stock was sold at an average price of $506.52, for a total value of $95,225.76. Following the transaction, the executive vice president now owns 5,506 shares in the company, valued at approximately $2,788,899.12. This represents a 3.30 % decrease in their ownership of the stock. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. Also, insider Jamie Samath sold 22,903 shares of the stock in a transaction on Friday, November 8th. The stock was sold at an average price of $525.00, for a total value of $12,024,075.00. Following the completion of the transaction, the insider now owns 8,757 shares in the company, valued at approximately $4,597,425. This represents a 72.34 % decrease in their ownership of the stock. The disclosure for this sale can be found here. Insiders have sold a total of 42,453 shares of company stock valued at $22,059,506 in the last 90 days. 0.90% of the stock is owned by corporate insiders.

Institutional Trading of Intuitive Surgical

Hedge funds have recently bought and sold shares of the business. Mirador Capital Partners LP grew its position in Intuitive Surgical by 1.4% in the 3rd quarter. Mirador Capital Partners LP now owns 3,526 shares of the medical equipment provider’s stock valued at $1,732,000 after purchasing an additional 50 shares during the period. M.E. Allison & CO. Inc. purchased a new position in Intuitive Surgical during the 4th quarter worth $449,000. Seilern Investment Management Ltd purchased a new position in Intuitive Surgical during the 4th quarter worth $82,517,000. Exome Asset Management LLC boosted its holdings in Intuitive Surgical by 16.8% during the 3rd quarter. Exome Asset Management LLC now owns 7,427 shares of the medical equipment provider’s stock worth $3,649,000 after acquiring an additional 1,069 shares during the last quarter. Finally, Consolidated Planning Corp boosted its holdings in Intuitive Surgical by 17.4% during the 3rd quarter. Consolidated Planning Corp now owns 8,099 shares of the medical equipment provider’s stock worth $3,979,000 after acquiring an additional 1,198 shares during the last quarter. Institutional investors and hedge funds own 83.64% of the company’s stock.

Intuitive Surgical Company Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.